Koskiniemi v. Jennings CA5

CourtCalifornia Court of Appeal
DecidedMay 23, 2025
DocketF087348
StatusUnpublished

This text of Koskiniemi v. Jennings CA5 (Koskiniemi v. Jennings CA5) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Koskiniemi v. Jennings CA5, (Cal. Ct. App. 2025).

Opinion

Filed 5/23/25 Koskiniemi v. Jennings CA5

NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIFTH APPELLATE DISTRICT

KENNETH KOSKINIEMI et al., F087348 Plaintiffs and Appellants, (Super. Ct. No. 21CECG03751) v.

MICHAEL JENNINGS et al., OPINION Defendants and Respondents.

APPEAL from a judgment of the Superior Court of Fresno County. D. Tyler Tharpe, Judge. Kasowitz Benson Torres, Jason S. Takenouchi; King & Spalding, Kellam McChesney Conover, Sarmad Khojasteh, and Ashley C. Parrish, for Plaintiffs and Appellants. Jared Gordon, for Defendant and Respondent Michael Jennings. Cozen O’Connor, Brett N. Taylor, Matthew E. Lewitz, and Alexander E. Robinson, for Defendants and Respondents Next Green Wave, NGW Holdings, LLC, Next Green Holdings Inc., Crossgate Capital US Holdings Corp., and Planet 13 Holdings Inc. -ooOoo- Plaintiffs Kenneth Koskiniemi and Micah-Luc Almeida appeal from a final judgment of dismissal entered after the trial court sustained defendants’ demurrers as to all causes of action, without leave to amend. We conclude the trial court erred in sustaining defendants’ demurrers. We therefore reverse the judgment of dismissal and remand the matter for further proceedings. PROCEDURAL BACKGROUND Plaintiffs and appellants Kenneth Koskiniemi and Micah-Luc Almeida (plaintiffs) initiated this action on December 17, 2021, against the following defendants and respondents: (1) Michael Jennings and (2) Next Green Wave LLC, NGW Holdings, LLC, Next Green Wave Holdings Inc., and Crossgate Capital US Holdings Corp. (collectively, NGW defendants). Plaintiffs’ complaint alleged seven causes of action against Jennings: breach of fiduciary duty; conversion; misappropriation of trade secrets; unjust enrichment; fraud; violation of the Unfair Competition Law (UCL); and constructive trust. The complaint further alleged six causes of action against the NGW defendants: aiding and abetting breach of fiduciary duty; aiding and abetting conversion; misappropriation of trade secrets; unjust enrichment; violation of the UCL; and constructive trust. Jennings and the NGW defendants filed demurrers on February 15, 2022. The trial court, on January 20, 2023, sustained the demurrers with leave to amend. Plaintiffs filed a first amended complaint (FAC) on February 9, 2023.1 The FAC realleged the same causes of action against Jennings and the NGW defendants as were alleged in the initial complaint. The FAC sought “actual, consequential, and compensatory damages” in the amount of $38 million, as well as injunctive relief to enjoin defendants from “continuing to use Plaintiffs’ trade secrets in their business operations.” Jennings and the NGW defendants then demurred to the FAC. On August 22, 2023, the trial court issued a tentative ruling sustaining the demurrers without leave to

1 The FAC added one additional defendant, Planet 13 Holdings, Inc. We will use the collective term “NGW defendants” to include Planet 13, Holdings, Inc.

2. amend. The following day, the trial court heard argument from the parties. On September 5, 2023, the court adopted its tentative ruling (without modification) as its final order and dismissed the FAC. This appeal followed. THE FIRST AMENDED COMPLAINT The FAC indicates the dispute at issue in this case arose from a partnership that Koskiniemi, Almeida, and Jennings formed in relation to seeds for specific strains of marijuana that were developed or engineered by Almeida when he legally grew marijuana, in California, for medicinal purposes. The FAC alleges that the partnership’s primary objects were (1) to publicize and brand Almeida’s seeds, and (2) to legally market the seeds in California, once adult recreational use of cannabis (and commercial sales) were legalized in the state. The FAC alleges the partners intended for the partnership’s activities to fully comport with applicable California laws. More specifically, the FAC alleges: “Almeida and Koskiniemi have been at the forefront of California’s legal cannabis industry since California legalized the cultivation of medicinal marijuana in 1996 through the adoption of Proposition 215, the Compassionate Use Act. After California enacted Senate Bill 420, The Medical Marijuana Program Act (‘MMPA’), in 2004, qualified patients in the State could cultivate, deliver, transport, and possess cannabis pursuant to a doctor’s recommendation. Under that regulatory regime, individuals like Almeida, were permitted to obtain a doctor’s recommendation to legally grow cannabis and develop proprietary cannabis strains using cross-breeding and genetic mapping.” The FAC adds: “Other medical cannabis pioneers were using similar techniques [as Almeida] to develop their own proprietary strains during this time in California. For example, the U.S. Patent and Trademark Office received applications for patents on proprietary cannabis strains developed by individuals in California as early as 2010, and issued the first plant patent on a cannabis strain in 2016 (based on a 2010 application.)”

3. The FAC states: “In 2008, Almeida began managing a warehouse in Richmond, California, where, pursuant to Proposition 215, the Compassionate Use Act of 1996, and the MMPA, he legally grew various marijuana strains pursuant to a doctor’s recommendation permitting him to grow cannabis legally. Almeida never sold any of the cannabis plants he grew or seeds he bred or otherwise profited from them.” Almeida was permitted “to legally develop proprietary cannabis strains using cross-breeding and genetic mapping, including the strains at issue in this action.” He “was meticulous to avoid running afoul of California’s medical cannabis regulations, and also feared that [any] commercial sale and distribution of the seeds would extinguish the proprietary nature of the strains and breeds he developed.” The FAC notes: “Almeida selected new strains first based on disease resistance, then vigor, followed by aromatic and visual qualities.” He “ultimately engaged Steep Hill labs in Berkeley, California, the state’s first legal cannabis genetics lab, to map the genes of the parents as well as the new strains so that he could determine their genetic makeup with 100% accuracy.” Koskiniemi “began growing at Almeida’s warehouse,” too. “By the late 2000s, Almeida and Koskiniemi were working together … growing innovative new strains as permitted under the MMPA, including ‘Loud,’ a remarkable strain known for its pungent smell and balanced flavor.” The FAC alleges, without specifying a date, that Almeida and Koskiniemi entered into an oral agreement to form a partnership named Loud Seeds. Through the partnership, “Almeida and Koskiniemi intended to sell Almeida’s seeds after California legalized adult-use recreational cannabis, and only after obtaining the proper licenses from the State.” The FAC notes: “Almeida would provide the seeds for the partnership and Koskiniemi would manage its operations and be the face of the partnership. The object, or purpose, of the partnership was to build the Loud Seeds brand around the proprietary cannabis seed strains and breeds legally developed by Almeida pursuant to Proposition 215 and the MMPA, and to monetize the intellectual property—the Loud

4. Seeds brand and genetically-unique and proprietary seed strains Almeida developed— after California legalized adult-use cannabis. The partnership never engaged in any conduct intended to generate a profit from the cultivation or sale of cannabis plants or seeds prior to legalization of adult-use cannabis, nor did it ever contemplate doing so.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gonzales v. Raich
545 U.S. 1 (Supreme Court, 2005)
Wong v. Tenneco, Inc.
702 P.2d 570 (California Supreme Court, 1985)
Lewis & Queen v. N. M. Ball Sons
308 P.2d 713 (California Supreme Court, 1957)
Barlow v. Collins
333 P.2d 64 (California Court of Appeal, 1958)
City of Torrance v. Workers' Compensation Appeals Board
650 P.2d 1162 (California Supreme Court, 1982)
Blank v. Kirwan
703 P.2d 58 (California Supreme Court, 1985)
Lee on v. Long
234 P.2d 9 (California Supreme Court, 1951)
Swenson v. File
475 P.2d 852 (California Supreme Court, 1970)
Elsbach v. Mulligan
136 P.2d 651 (California Court of Appeal, 1943)
Gherman v. Colburn
72 Cal. App. 3d 544 (California Court of Appeal, 1977)
Crosstalk Productions, Inc. v. Jacobson
76 Cal. Rptr. 2d 615 (California Court of Appeal, 1998)
Vierra v. Workers' Compensation Appeals Board
65 Cal. Rptr. 3d 423 (California Court of Appeal, 2007)
People v. Hochanadel
176 Cal. App. 4th 997 (California Court of Appeal, 2009)
McIntosh v. Mills
17 Cal. Rptr. 3d 66 (California Court of Appeal, 2004)
Casey v. U.S. Bank National Ass'n
26 Cal. Rptr. 3d 401 (California Court of Appeal, 2005)
Navarro v. Perron
19 Cal. Rptr. 3d 198 (California Court of Appeal, 2004)
Qualified Patients Assn. v. City of Anaheim
187 Cal. App. 4th 734 (California Court of Appeal, 2010)
Lazar v. Hertz Corp.
82 Cal. Rptr. 2d 368 (California Court of Appeal, 1999)
Kashani v. TSANN KUEN CHINA ENTERPRISE CO.
13 Cal. Rptr. 3d 174 (California Court of Appeal, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Koskiniemi v. Jennings CA5, Counsel Stack Legal Research, https://law.counselstack.com/opinion/koskiniemi-v-jennings-ca5-calctapp-2025.